2021-06-20
Published Date
Healthcare
Industry
122
Pages
The global Hereditary Angioedema market is growing with significant growth from last couple of years. In the year 2020, the market of Hereditary Angioedema was valued at USD XX Million and is expected to reach USD XXX million by the end of the year 2027. ,
The report is designed to offer very important and crucial information about the Hereditary Angioedema market and industry. For the purpose of this study, the market of Hereditary Angioedema has been segmented into type, application, regions and countries. Each segment of the report will provide a detailed analysis of the market in terms of quantitative and qualitative information, the report offers market revenue (USD Million), market share in %, market CAGR from 2021 to 2027.
The report provides a detailed qualitative analysis of the Hereditary Angioedema market which includes Market Drivers to explain the driving factors of the market and demand, Market Challenges to explain the restraints of the market and growth and Market Opportunities to explain the upcoming trends and opportunities left for the newcomers of the market and where can the existing companies focus in order to gain competitive advantage. The Hereditary Angioedema report also provides a detailed Porter's Five Forces, Micro and Macro Economic analysis which can help the readers and the users of the report to understand and draw a sound business decision.
The readers of the report will have a deep , insightful analysis that will help in understanding the market size, market share, CAGR, country specific analysis and market share for Hereditary Angioedema market.
Market Segmentation
One of the very important chapter of Hereditary Angioedema market report is competitive analysis. In this chapter, we have presented a detailed overview of the competition and have provided the market revenue of each company along with the market share.
The companies mentioned in the report are:
Pharming Group NV
Shire plc
CSL Limited
iBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
Note: We can also add companies which are not part of the above list
Global Hereditary Angioedema Market Analysis By Type
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist
In the year 2020, C1 Esterase Inhibitor segment had XX% of market share and in terms of value, the C1 Esterase Inhibitor market was valued at USD XX Million. , It is expected that C1 Esterase Inhibitor will have XX% of market share by the end of year 2027 and the incremental growth from 2021 till 2027 is expected to be USD XX Million.
Global Hereditary Angioedema Market Analysis By Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies segment is expected to account for XX% of market share by the end of year 2027 from XX% in 2020. The Retail Pharmacies segment is expected to grow at USD XX million by the end of year 2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The following regions has been further bifurcated into countries to provide an insightful analysis for the readers.
Global Hereditary Angioedema market: regional analysis, the major regions covered in the report are:
North America
Europe
China
Japan
Southeast Asia
India
The study objectives are:
To analyze and research the Hereditary Angioedema Market status and future forecast.
To present the key Hereditary Angioedema Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Frequently Asked Questions - FAQ:
How big is the opportunity for the Hereditary Angioedema market
What are the recent industry development that can be implemented to generate additional revenue streams
Who are the major players operating in the Hereditary Angioedema market Which companies are the front runners
Table of Contents
Executive Summary
1 Industry Overview of Hereditary Angioedema
1.1 Definition of Hereditary Angioedema
1.2 Hereditary Angioedema Segment by Type
1.2.1 Global Hereditary Angioedema Production Growth Rate Comparison by Types (2016-2027)
1.2.2 C1 Esterase Inhibitor
1.2.3 Kallikrein Inhibitor
1.2.4 Selective Bradykinin B2 Receptor Antagonist
1.3 Hereditary Angioedema Segment by Applications
1.3.1 Global Hereditary Angioedema Consumption Comparison by Applications (2016-2027)
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Global Hereditary Angioedema Overall Market
1.4.1 Global Hereditary Angioedema Revenue (2016-2027)
1.4.2 Global Hereditary Angioedema Production (2016-2027)
1.4.3 North America Hereditary Angioedema Status and Prospect (2016-2027)
1.4.4 Europe Hereditary Angioedema Status and Prospect (2016-2027)
1.4.5 China Hereditary Angioedema Status and Prospect (2016-2027)
1.4.6 Japan Hereditary Angioedema Status and Prospect (2016-2027)
1.4.7 Southeast Asia Hereditary Angioedema Status and Prospect (2016-2027)
1.4.8 India Hereditary Angioedema Status and Prospect (2016-2027)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Hereditary Angioedema
2.3 Manufacturing Process Analysis of Hereditary Angioedema
2.4 Industry Chain Structure of Hereditary Angioedema
3 Development and Manufacturing Plants Analysis of Hereditary Angioedema
3.1 Capacity and Commercial Production Date
3.2 Global Hereditary Angioedema Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Hereditary Angioedema
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Hereditary Angioedema Production and Capacity Analysis
4.2 Hereditary Angioedema Revenue Analysis
4.3 Hereditary Angioedema Price Analysis
4.4 Market Concentration Degree
5 Hereditary Angioedema Regional Market Analysis
5.1 Hereditary Angioedema Production by Regions
5.1.1 Global Hereditary Angioedema Production by Regions
5.1.2 Global Hereditary Angioedema Revenue by Regions
5.2 Hereditary Angioedema Consumption by Regions
5.3 North America Hereditary Angioedema Market Analysis
5.3.1 North America Hereditary Angioedema Production
5.3.2 North America Hereditary Angioedema Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Hereditary Angioedema Import and Export
5.4 Europe Hereditary Angioedema Market Analysis
5.4.1 Europe Hereditary Angioedema Production
5.4.2 Europe Hereditary Angioedema Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Hereditary Angioedema Import and Export
5.5 China Hereditary Angioedema Market Analysis
5.5.1 China Hereditary Angioedema Production
5.5.2 China Hereditary Angioedema Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Hereditary Angioedema Import and Export
5.6 Japan Hereditary Angioedema Market Analysis
5.6.1 Japan Hereditary Angioedema Production
5.6.2 Japan Hereditary Angioedema Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Hereditary Angioedema Import and Export
5.7 Southeast Asia Hereditary Angioedema Market Analysis
5.7.1 Southeast Asia Hereditary Angioedema Production
5.7.2 Southeast Asia Hereditary Angioedema Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Hereditary Angioedema Import and Export
5.8 India Hereditary Angioedema Market Analysis
5.8.1 India Hereditary Angioedema Production
5.8.2 India Hereditary Angioedema Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Hereditary Angioedema Import and Export
6 Hereditary Angioedema Segment Market Analysis (by Type)
6.1 Global Hereditary Angioedema Production by Type
6.2 Global Hereditary Angioedema Revenue by Type
6.3 Hereditary Angioedema Price by Type
7 Hereditary Angioedema Segment Market Analysis (by Application)
7.1 Global Hereditary Angioedema Consumption by Application
7.2 Global Hereditary Angioedema Consumption Market Share by Application (2016-2020)
8 Hereditary Angioedema Major Manufacturers Analysis
8.1 Pharming Group NV
8.1.1 Pharming Group NV Hereditary Angioedema Production Sites and Area Served
8.1.2 Pharming Group NV Product Introduction, Application and Specification
8.1.3 Pharming Group NV Hereditary Angioedema Production, Revenue, Ex-factory Price and Gross Margin (2016-2020)
8.1.4 Main Business and Markets Served
8.2 Shire plc
8.2.1 Shire plc Hereditary Angioedema Production Sites and Area Served
8.2.2 Shire plc Product Introduction, Application and Specification
8.2.3 Shire plc Hereditary Angioedema Production, Revenue, Ex-factory Price and Gross Margin (2016-2020)
8.2.4 Main Business and Markets Served
8.3 CSL Limited
8.3.1 CSL Limited Hereditary Angioedema Production Sites and Area Served
8.3.2 CSL Limited Product Introduction, Application and Specification
8.3.3 CSL Limited Hereditary Angioedema Production, Revenue, Ex-factory Price and Gross Margin (2016-2020)
8.3.4 Main Business and Markets Served
8.4 iBio Inc.
8.4.1 iBio Inc. Hereditary Angioedema Production Sites and Area Served
8.4.2 iBio Inc. Product Introduction, Application and Specification
8.4.3 iBio Inc. Hereditary Angioedema Production, Revenue, Ex-factory Price and Gross Margin (2016-2020)
8.4.4 Main Business and Markets Served
8.5 BioCryst Pharmaceuticals, Inc.
8.5.1 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Production Sites and Area Served
8.5.2 BioCryst Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Production, Revenue, Ex-factory Price and Gross Margin (2016-2020)
8.5.4 Main Business and Markets Served
8.6 Ionis Pharmaceuticals, Inc.
8.6.1 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Production Sites and Area Served
8.6.2 Ionis Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Production, Revenue, Ex-factory Price and Gross Margin (2016-2020)
8.6.4 Main Business and Markets Served
9 Development Trend of Analysis of Hereditary Angioedema Market
9.1 Global Hereditary Angioedema Market Trend Analysis
9.1.1 Global Hereditary Angioedema Market Size (Volume and Value) Forecast 2021-2027
9.2 Hereditary Angioedema Regional Market Trend
9.2.1 North America Hereditary Angioedema Forecast 2021-2027
9.2.2 Europe Hereditary Angioedema Forecast 2021-2027
9.2.3 China Hereditary Angioedema Forecast 2021-2027
9.2.4 Japan Hereditary Angioedema Forecast 2021-2027
9.2.5 Southeast Asia Hereditary Angioedema Forecast 2021-2027
9.2.6 India Hereditary Angioedema Forecast 2021-2027
9.3 Hereditary Angioedema Market Trend (Product Type)
9.4 Hereditary Angioedema Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Hereditary Angioedema Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
List of Tables and Figures
Figure Picture of Hereditary Angioedema
Table Global Hereditary Angioedema Production (MT) Growth Rate Comparison by Types (2016-2027)
Figure Global Hereditary Angioedema Production Market Share by Types in 2020
Figure C1 Esterase Inhibitor Product Picture
Figure Kallikrein Inhibitor Product Picture
Figure Selective Bradykinin B2 Receptor Antagonist Product Picture
Table Global Hereditary Angioedema Consumption (MT) Comparison by Applications (2016-2027)
Figure Global Hereditary Angioedema Consumption Market Share by Applications in 2020
Figure Retail Pharmacies
Figure Hospital Pharmacies
Figure Online Pharmacies
Figure Global Hereditary Angioedema Revenue (Million USD) (2016-2027)
Figure Global Hereditary Angioedema Production (MT) (2016-2027)
Figure North America Hereditary Angioedema Market Size (Million USD) (2016-2027)
Figure Europe Hereditary Angioedema Market Size (Million USD) (2016-2027)
Figure China Hereditary Angioedema Market Size (Million USD) (2016-2027)
Figure Japan Hereditary Angioedema Market Size (Million USD) (2016-2027)
Figure Southeast Asia Hereditary Angioedema Market Size (Million USD) (2016-2027)
Figure India Hereditary Angioedema Market Size (Million USD) (2016-2027)
Table Hereditary Angioedema Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Hereditary Angioedema in 2020
Figure Manufacturing Process Analysis of Hereditary Angioedema
Figure Industry Chain Structure of Hereditary Angioedema
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Hereditary Angioedema Manufacturing Plants Distribution
Table Hereditary Angioedema Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Hereditary Angioedema Capacity (MT) of Major Manufacturers (2016-2020)
Table Hereditary Angioedema Production (MT) of Major Manufacturers (2016-2020)
Table Hereditary Angioedema Production Market Share of Major Manufacturers (2016-2020)
Figure Hereditary Angioedema Production Share by Manufacturers in 2020
Table Hereditary Angioedema Revenue (Million US$) of Major Manufacturers (2016-2020)
Table Hereditary Angioedema Revenue Market Share of Major Manufacturers (2016-2020)
Figure Hereditary Angioedema Revenue Share by Manufacturers in 2020
Table Hereditary Angioedema Average Price (USD/Kg) of Major Manufacturers (2016-2020)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Hereditary Angioedema Production by Regions 2016-2020 (MT)
Table Global Hereditary Angioedema Production Market Share by Regions 2016-2020
Figure Global Hereditary Angioedema Production Market Share by Regions in 2020
Table Global Hereditary Angioedema Revenue by Regions 2016-2020 (Million USD)
Table Global Hereditary Angioedema Revenue Market Share by Regions 2016-2020
Figure Global Hereditary Angioedema Revenue Market Share by Regions in 2020
Table Global Hereditary Angioedema Consumption by Regions 2016-2020 (MT)
Table Global Hereditary Angioedema Consumption Market Share by Regions 2016-2020
Figure North America Hereditary Angioedema Production Growth Rate 2016-2020 (MT)
Figure North America Hereditary Angioedema Revenue Growth Rate 2016-2020 (Million USD)
Table North America Hereditary Angioedema Production, Consumption Import and Export (MT)
Figure Europe Hereditary Angioedema Production Growth Rate 2016-2020 (MT)
Figure Europe Hereditary Angioedema Revenue Growth Rate 2016-2020 (Million USD)
Table Europe Hereditary Angioedema Production, Consumption Import and Export (MT)
Figure China Hereditary Angioedema Production Growth Rate 2016-2020 (MT)
Figure China Hereditary Angioedema Revenue Growth Rate 2016-2020 (Million USD)
Table China Hereditary Angioedema Production, Consumption Import and Export (MT)
Figure Japan Hereditary Angioedema Production Growth Rate 2016-2020 (MT)
Figure Japan Hereditary Angioedema Revenue Growth Rate 2016-2020 (Million USD)
Table Japan Hereditary Angioedema Production, Consumption Import and Export (MT)
Figure Southeast Asia Hereditary Angioedema Production Growth Rate 2016-2020 (MT)
Figure Southeast Asia Hereditary Angioedema Revenue Growth Rate 2016-2020 (Million USD)
Table Southeast Asia Hereditary Angioedema Production, Consumption Import and Export (MT)
Figure India Hereditary Angioedema Production Growth Rate 2016-2020 (MT)
Figure India Hereditary Angioedema Revenue Growth Rate 2016-2020 (Million USD)
Table India Hereditary Angioedema Production, Consumption Import and Export (MT)
Figure Global Consumption Hereditary Angioedema Market Share by Application (2016-2020)
Figure Global Value (Consumption) Hereditary Angioedema Market Share by Application (2016-2020)
Table Pharming Group NV Hereditary Angioedema Production Sites and Area Served
Table Pharming Group NV Hereditary Angioedema Product Introduction, Application and Specification
Table Pharming Group NV Hereditary Angioedema Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2016-2020)
Table Pharming Group NV Hereditary Angioedema Production Growth Rate (2016-2020)
Table Pharming Group NV Hereditary Angioedema Production Market Share (2016-2020)
Figure Pharming Group NV Hereditary Angioedema Revenue Market Share (2016-2020)
Table Pharming Group NV Hereditary Angioedema Main Business and Markets Served
Table Shire plc Hereditary Angioedema Production Sites and Area Served
Table Shire plc Hereditary Angioedema Product Introduction, Application and Specification
Table Shire plc Hereditary Angioedema Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2016-2020)
Table Shire plc Hereditary Angioedema Production Growth Rate (2016-2020)
Table Shire plc Hereditary Angioedema Production Market Share (2016-2020)
Figure Shire plc Hereditary Angioedema Revenue Market Share (2016-2020)
Table Shire plc Hereditary Angioedema Main Business and Markets Served
Table CSL Limited Hereditary Angioedema Production Sites and Area Served
Table CSL Limited Hereditary Angioedema Product Introduction, Application and Specification
Table CSL Limited Hereditary Angioedema Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2016-2020)
Table CSL Limited Hereditary Angioedema Production Growth Rate (2016-2020)
Table CSL Limited Hereditary Angioedema Production Market Share (2016-2020)
Figure CSL Limited Hereditary Angioedema Revenue Market Share (2016-2020)
Table CSL Limited Hereditary Angioedema Main Business and Markets Served
Table iBio Inc. Hereditary Angioedema Production Sites and Area Served
Table iBio Inc. Hereditary Angioedema Product Introduction, Application and Specification
Table iBio Inc. Hereditary Angioedema Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2016-2020)
Table iBio Inc. Hereditary Angioedema Production Growth Rate (2016-2020)
Table iBio Inc. Hereditary Angioedema Production Market Share (2016-2020)
Figure iBio Inc. Hereditary Angioedema Revenue Market Share (2016-2020)
Table iBio Inc. Hereditary Angioedema Main Business and Markets Served
Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Production Sites and Area Served
Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Product Introduction, Application and Specification
Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2016-2020)
Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Production Growth Rate (2016-2020)
Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Production Market Share (2016-2020)
Figure BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Revenue Market Share (2016-2020)
Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Main Business and Markets Served
Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Production Sites and Area Served
Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Product Introduction, Application and Specification
Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2016-2020)
Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Production Growth Rate (2016-2020)
Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Production Market Share (2016-2020)
Figure Ionis Pharmaceuticals, Inc. Hereditary Angioedema Revenue Market Share (2016-2020)
Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Main Business and Markets Served
Figure Global Hereditary Angioedema Production (MT) Growth Rate Forecast 2021-2027
Figure Global Hereditary Angioedema Revenue (Million USD) Growth Rate Forecast 2021-2027
Figure Global Hereditary Angioedema Sales Price (USD/Kg) Forecast 2021-2027
Figure North America Hereditary Angioedema Production Growth Rate Forecast 2021-2027 (MT)
Figure North America Hereditary Angioedema Revenue Growth Rate Forecast 2021-2027 (Million USD)
Figure Europe Hereditary Angioedema Production Growth Rate Forecast 2021-2027 (MT)
Figure Europe Hereditary Angioedema Revenue Growth Rate Forecast 2021-2027 (Million USD)
Figure China Hereditary Angioedema Production Growth Rate Forecast 2021-2027 (MT)
Figure China Hereditary Angioedema Revenue Growth Rate Forecast 2021-2027 (Million USD)
Figure Japan Hereditary Angioedema Production Growth Rate Forecast 2021-2027 (MT)
Figure Japan Hereditary Angioedema Revenue Growth Rate Forecast 2021-2027 (Million USD)
Figure Southeast Asia Hereditary Angioedema Production Growth Rate Forecast 2021-2027 (MT)
Figure Southeast Asia Hereditary Angioedema Revenue Growth Rate Forecast 2021-2027 (Million USD)
Figure India Hereditary Angioedema Production Growth Rate Forecast 2021-2027 (MT)
Figure India Hereditary Angioedema Revenue Growth Rate Forecast 2021-2027 (Million USD)
Table Global Production (MT) of Hereditary Angioedema by Type (2021-2027)
Table Global Consumption (MT) of Hereditary Angioedema by Application (2021-2027)
Table Hereditary Angioedema Distributors List
Table Hereditary Angioedema Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources